{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:45:09Z","timestamp":1792223109349,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Oncology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.oraloncology.2012.06.017","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T01:48:31Z","timestamp":1343267311000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Positive and negative regulation of podoplanin expression by TGF-\u03b2 and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines"],"prefix":"10.1016","volume":"49","author":[{"given":"Mitsuhiko","family":"Ohta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harunari","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Maseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisaku","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayao","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oraloncology.2012.06.017_b0005","first-page":"225","article-title":"Cancer statistics","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.oraloncology.2012.06.017_b0010","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ijrobp.2008.10.040","article-title":"Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio (chemo) therapy","volume":"73","author":"Vormittag","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4\u20135","key":"10.1016\/j.oraloncology.2012.06.017_b0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.oraloncology.2008.05.017","article-title":"Current concepts in management of oral cancer-surgery","volume":"45","author":"Shah","year":"2009","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.oraloncology.2012.06.017_b0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.oraloncology.2012.06.017_b0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.oraloncology.2011.06.508","article-title":"Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy","volume":"47","author":"Kreppel","year":"2011","journal-title":"Oral Oncol"},{"issue":"3","key":"10.1016\/j.oraloncology.2012.06.017_b0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1368-8375(02)00162-8","article-title":"Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management","volume":"39","author":"Nagpal","year":"2003","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oraloncology.2012.06.017_b0035","first-page":"1141","article-title":"Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis","volume":"151","author":"Breitender-Geleff","year":"1997","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.oraloncology.2012.06.017_b0040","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/modpathol.3880543","article-title":"Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi\u2019s sarcoma and a subset of angiosarcomas","volume":"15","author":"Kohn","year":"2002","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.oraloncology.2012.06.017_b0045","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.3800580","article-title":"Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation","volume":"19","author":"Dumoff","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.oraloncology.2012.06.017_b0050","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1038\/sj.onc.1207869","article-title":"Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors","volume":"23","author":"Kato","year":"2004","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.oraloncology.2012.06.017_b0055","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00401-006-0063-y","article-title":"Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression","volume":"111","author":"Mishima","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.oraloncology.2012.06.017_b0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000086952","article-title":"Enhanced expression of Aggrus (T1alpha\/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma","volume":"26","author":"Kato","year":"2005","journal-title":"Tumor Biol"},{"issue":"6","key":"10.1016\/j.oraloncology.2012.06.017_b0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00428-010-0915-7","article-title":"Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations","volume":"456","author":"Kreppel","year":"2010","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.oraloncology.2012.06.017_b0070","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/cncr.22061","article-title":"Overexpression of podoplanin in oral cancer and its association with poor clinical outcome","volume":"107","author":"Yuan","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.oraloncology.2012.06.017_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6603518","article-title":"The potential role of podoplanin in tumour invasion","volume":"96","author":"Wicki","year":"2007","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.oraloncology.2012.06.017_b0080","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/ijc.25795","article-title":"Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx","volume":"129","author":"Huber","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.oraloncology.2012.06.017_b0085","first-page":"767","article-title":"Purification of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26","volume":"55","author":"Toyoshima","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.oraloncology.2012.06.017_b0090","doi-asserted-by":"crossref","first-page":"51599","DOI":"10.1074\/jbc.M309935200","article-title":"Molecular identification of aggrus\/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors","volume":"278","author":"Kato","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.oraloncology.2012.06.017_b0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbrc.2008.05.163","article-title":"Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431","volume":"373","author":"Atsumi","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.oraloncology.2012.06.017_b0100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.febslet.2007.12.028","article-title":"Induction of podoplanin by transforming growth factor-\u03b2 in human fibrosarcoma","volume":"582","author":"Suzuki","year":"2008","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.oraloncology.2012.06.017_b0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jdermsci.2011.11.011","article-title":"Podoplanin expression in wound and hyperproliferative psoriatic epidermis: Regulation by TGF-\u03b2 and STAT-3 activating cytokines, IFN-\u03b3, IL-6 and IL-22","volume":"65","author":"Honma","year":"2012","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.oraloncology.2012.06.017_b0110","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/sj.bjc.6602802","article-title":"Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients","volume":"93","author":"Ito","year":"2005","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.oraloncology.2012.06.017_b0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0714.2007.00529.x","article-title":"Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2\u201340 and podoplanin antibody: an analysis in comparison with angiogenesis","volume":"36","author":"Ohno","year":"2007","journal-title":"J Oral Pathol Med"},{"issue":"11","key":"10.1016\/j.oraloncology.2012.06.017_b0120","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/j.1349-7006.2009.01295.x","article-title":"Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung","volume":"100","author":"Shimada","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.oraloncology.2012.06.017_b0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2199-8-20","article-title":"Sp1\/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells","volume":"8","author":"Hantusch","year":"2007","journal-title":"BMC Mol Biol"},{"key":"10.1016\/j.oraloncology.2012.06.017_b0130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/37284","article-title":"TGF-beta signaling from cell membrane to nucleus through SMAD proteins","volume":"390","author":"Heldin","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.oraloncology.2012.06.017_b0135","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1349-7006.2012.02209.x","article-title":"Cancer-associated orthotopic myofibroblasts stimulate the motility of gastric carcinoma cells","volume":"103","author":"Fuyuhiro","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1016\/j.oraloncology.2012.06.017_b0140","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1101\/gad.1413306","article-title":"Loss of transforming growth factor-\u03b2 type II receptor promotes metastatic head-and-neck squamous cell carcinoma","volume":"20","author":"Lu","year":"2006","journal-title":"Genes Dev"},{"issue":"11","key":"10.1016\/j.oraloncology.2012.06.017_b0145","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/gcc.20808","article-title":"MiR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma","volume":"49","author":"Cortez","year":"2010","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Oral Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368837512002151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368837512002151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:04:48Z","timestamp":1761282288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368837512002151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1368837512002151"],"URL":"https:\/\/doi.org\/10.1016\/j.oraloncology.2012.06.017","relation":{},"ISSN":["1368-8375"],"issn-type":[{"value":"1368-8375","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive and negative regulation of podoplanin expression by TGF-\u03b2 and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines","name":"articletitle","label":"Article Title"},{"value":"Oral Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oraloncology.2012.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}